FSSAI issues notices to Zydus Wellness, Nestle India
SENSEX 73,709.69 -143.21 NIFTY 22,811.35 -77.60 CRUDEOIL 9,178.00 -133.00 GOLD 145,986.00 -533.00 SILVER 209,115.00 -2,370.00 SENSEX 73,709.69 -143.21 NIFTY 22,811.35 -77.60 NIFTY 22,811.35 -77.60 CRUDEOIL 9,178.00 -133…

-143.21
NIFTY 22,811.35-77.60
CRUDEOIL 9,178.00-133.00
GOLD 145,986.00-533.00
SILVER 209,115.00-2,370.00
SENSEX 73,709.69-143.21
NIFTY 22,811.35-77.60
NIFTY 22,811.35-77.60
CRUDEOIL 9,178.00-133.00
CRUDEOIL 9,178.00-133.00
GOLD 145,986.00-533.00
'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.FSSAI said it has issued notices to Nestle India for “misleading claims and non-compliant promotions” involving two food products ‘Lactogen Pro 1 Powder’ and ‘Nan Excella Pro Stage 1’
By BL New Delhi Bureau
Updated - October 21, 2026 at 10:37 PM. | New Delhi, October 21The logo of the Food Safety and Standards Authority of India (FSSAI) | Photo Credit: bl-online Administrator
The Food Safety and Standards Authority of India has sent notices to Zydus Wellness and Nestle India over misleading claims made for certain products.
In a social media post, FSSAI said it has issued a notice to Zydus Wellness Products Ltd regarding misleading claims and ads for Complan. It said that claims such as “Supports Concentration and Memory” and “2x Faster Growth” among others were in violation of the regulations. It has also sought scientific for certain other claims made by the company.
Misleading Claims
In another social media post, FSSAI said it has issued notices to Nestle India for “misleading claims and non-compliant promotions” involving two food products ‘Lactogen Pro 1 Powder’ and ‘Nan Excella Pro Stage 1’. In the notice issued for Lactogen Pro 1 powder, FSSAI said the company has claimed, in its labelling and advertisement material, that product “contains Whey Protein, which is a part of milk protein that is easy to digest”. The regulator has sought scientific substantiation for this claim.
In the product Nan Excella Pro Stage 1, the FSSAI said that claim “5 HMOs helps support normal immune system” was considered to imply that the product is suitable for supporting the immune system. “The claim was considered non-compliant with provisions prohibiting claims relating to the prevention, alleviation, treatment or cure of any disease, disorder or particular physiological condition, unless specifically permitted under applicable regulations,” the regulator said.
Nestle India’s spokesperson said: ”FSSAI’s recent post reiterates the points raised in its earlier post of 18 September regarding product labels. We have already submitted our detailed response to FSSAI on these matters.”
Published on October 21, 2026
THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!- Access 10 free stories per month
- Get notified by email for early preview to new features, discounts & offers
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



